Literature DB >> 15540243

Granulocyte--colony-stimulating factor (Filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase myelogenous leukemia.

Heather G Jørgensen, Mhairi Copland, Tessa L Holyoake.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15540243     DOI: 10.1002/cncr.20742

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  6 in total

1.  Berbamine overcomes imatinib-induced neutropenia and permits cytogenetic responses in Chinese patients with chronic-phase chronic myeloid leukemia.

Authors:  Yanmin Zhao; Yamin Tan; Gongqiang Wu; Lizhen Liu; Yingjia Wang; Yi Luo; Jimin Shi; He Huang
Journal:  Int J Hematol       Date:  2011-07-05       Impact factor: 2.490

Review 2.  Hematologic toxicities of small molecule tyrosine kinase inhibitors.

Authors:  Nicholas A Barber; Wais Afzal; Mojtaba Akhtari
Journal:  Target Oncol       Date:  2011-11-30       Impact factor: 4.493

Review 3.  Pathogenesis, treatment effects, and resistance dynamics in chronic myeloid leukemia--insights from mathematical model analyses.

Authors:  Ingo Roeder; Ingmar Glauche
Journal:  J Mol Med (Berl)       Date:  2007-07-28       Impact factor: 4.599

4.  New experimental and theoretical investigations of hematopoietic stem cells and chronic myeloid leukemia.

Authors:  Ingo Roeder; Mark d'Inverno
Journal:  Blood Cells Mol Dis       Date:  2009-05-02       Impact factor: 3.039

5.  Imatinib plus Granulocyte Colony-Stimulating Factor in Chronic Myeloid Leukemia Patients Who Have Achieved Partial or Complete Cytogenetic Response while on Imatinib.

Authors:  Baijun Fang; Ling Mai; Ning Li; Yongping Song; Robert Chunhua Zhao
Journal:  Case Rep Oncol       Date:  2011-04-02

Review 6.  European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia.

Authors:  J L Steegmann; M Baccarani; M Breccia; L F Casado; V García-Gutiérrez; A Hochhaus; D-W Kim; T D Kim; H J Khoury; P Le Coutre; J Mayer; D Milojkovic; K Porkka; D Rea; G Rosti; S Saussele; R Hehlmann; R E Clark
Journal:  Leukemia       Date:  2016-04-28       Impact factor: 11.528

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.